Authors
Latest:
Developing New Mass Spectrometry Solutions: From Individual Membrane Protein Complexes to In-Vivo Proteome DynamicsHigh speed MALDI mass spectrometry instrumentation drives multidisciplinary membrane proteomics research.
Latest:
An Integrated Approach to Shipping Liquid in Single-Use SystemsIncreased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.
Latest:
An Integrated Approach to Shipping Liquid in Single-Use SystemsIncreased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.
Latest:
Impact of Agitator Design on Bioreactor PerformanceAerobic bioprocesses are highly dependent upon the oxygen transfer rate (OTR) from sparged to dissolved gas. The relatively low solubility of oxygen, however, makes the choice of mixer impeller configuration a critical design factor for the bioreactor vessel. This article describes a series of experiments and computational fluid dynamics (CFD) simulations to detail the effect of mixer configuration on the efficiency and effectiveness of a bioreactor vessel with respect to blend time and mass transfer.
Latest:
Impact of Agitator Design on Bioreactor PerformanceAerobic bioprocesses are highly dependent upon the oxygen transfer rate (OTR) from sparged to dissolved gas. The relatively low solubility of oxygen, however, makes the choice of mixer impeller configuration a critical design factor for the bioreactor vessel. This article describes a series of experiments and computational fluid dynamics (CFD) simulations to detail the effect of mixer configuration on the efficiency and effectiveness of a bioreactor vessel with respect to blend time and mass transfer.
Latest:
Drug Discovery and Development in IndiaHope abounds for local drug discovery companies despite challenges at home.
Latest:
The Evolving War on Drug PricesImmuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.
Latest:
Value-Based Healthcare in the: United KingdomBio/pharmaceutical manufacturers in the UK face challenges in proving that their drugs are worth the price.
Latest:
Pre-use Filter-Integrity Testing: To Test or Not To Test?There is no harmonized guidance on pre-use integrity testing of sterilizing filters, prompting discussion among users as to whether such testing is necessary.
Latest:
Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish RequirementsReady-to-use components eliminate the need for component preparation by the drug product manufacturer, enabling them to streamline their processes and focus on their core competencies, such as drug product development and manufacturing.
Latest:
Relevance RegainedCompanies risk drowning in alphabet soup if the latest three-letter acronym improvement strategy isn't clearly linked to business strategy.
Latest:
Finding Opportunities in BrazilChanges in the country’s political landscape may affect the pharmaceutical industry market in the future.
Latest:
USP Workshop Focuses on BiologicsThe workshop focused on topics specific to biologics, including particulate control and determination, becoming the first workshop of its kind for the organization.
Latest:
Identification and Quantification of Trace-Level Protein ImpuritiesThe authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.
Latest:
Identification and Quantification of Trace-Level Protein ImpuritiesThe authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.
Latest:
Identification and Quantification of Trace-Level Protein ImpuritiesThe authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.
Latest:
Identification and Quantification of Trace-Level Protein ImpuritiesThe authors discuss the development of a simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics.
Latest:
Modular Facility Design Maximizes Space FlexiblyVetter's FOYA award-winning facility is an example of a flexible pharmaceutical and biopharmaceutical modular facility design that allows expansion of space without affecting existing operations.
Latest:
The Future of Dosage FormsHow will the move to more specialized and personalized medicines impact drug delivery and dosage forms?
Latest:
USP Workshop Focuses on BiologicsThe workshop focused on topics specific to biologics, including particulate control and determination, becoming the first workshop of its kind for the organization.
Latest:
Moisture Matters in Lyophilized Drug ProductUsing an alternate moisture-generation method may provide more accurate data for regulatory submissions.
Latest:
The Power of In Vitro Assays in Immuno-OncologyThe combination of translatable in-vitro and in-vivo assays, coupled with expertise in immunology and oncology helps facilitate the progression of novel oncology therapeutics from hit identification to investigational new drug submission.
Latest:
A Look Ahead at Manufacturing and RegulationFDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, and overall approaches.
Latest:
Healthcare Reform and Next Battles for IndustryThis guest blog was written by Christie Bloomquist is a partner in health practice at Hogan Lovells, a global legal practice firm based in Washington DC.
Latest:
Creating a Holistic Procurement SystemThe procurement organization rethinks sourcing for maximum efficiency and results.
Latest:
Outsourcing stem cell storageWhy is the correct storage of stem cells so important for the future of medical innovation?
Latest:
Opportunities and Challenges in the Development of Stem-Cell TherapiesStem cells are being developed to treat a diverse set of conditions, including spinal cord injury, amyotrophic lateral sclerosis, macular degeneration, Parkinsons disease, and Type I diabetes. But the challenges in moving from the laboratory to the clinic are formidable.
Latest:
Advancing Pharma’s Social Media Listening AnalyticsThe pharmaceutical industry still lags other industries in spending on outbound social media programs that engage customers directly.
